journal article·2021-10-26Open access

Apolipoprotein Mimetic Peptide Inhibits Neutrophil-Driven Inflammatory Damage via Membrane Remodeling and Suppression of Cell Lysis

Michelle W. Lee, Elizabeth Wei-Chia Luo, Carlos Silvestre-Roig, Yashes Srinivasan, Kiyotaka Akabori, Patricia Lemnitzer, Nathan W. Schmidt, Ghee Hwee Lai, Christian D. Santangelo, Oliver Soehnlein, Gerard C. L. Wong

ACS Nano· Volume 15· Issue 10

Abstract

Neutrophils are crucial for host defense but are notorious for causing sterile inflammatory damage. Activated neutrophils in inflamed tissue can liberate histone H4, which was recently shown to perpetuate inflammation by permeating membranes via the generation of negative Gaussian curvature (NGC), leading to lytic cell death. Here, we show that it is possible to build peptides or proteins that cancel NGC in membranes and thereby suppress pore formation, and demonstrate that they can inhibit H4 membrane remodeling and thereby reduce histone H4-driven lytic cell death and resultant inflammation. As a demonstration of principle, we use apolipoprotein A-I (apoA-I) mimetic peptide apoMP1. X-ray structural studies and theoretical calculations show that apoMP1 induces nanoscopic positive Gaussian curvature (PGC), which interacts with the NGC induced by the N-terminus of histone H4 (H4n) to inhibit membrane permeation. Interestingly, we show that induction of PGC can inhibit membrane-permeating activity in general and “turn off” diverse membrane-permeating molecules besides H4n. In vitro experiments show an apoMP1 dose-dependent rescue of H4 cytotoxicity. Using a mouse model, we show that tissue accumulation of neutrophils, release of neutrophil extracellular traps (NETs), and extracellular H4 all strongly correlate independently with local tissue cell death in multiple organs, but administration of apoMP1 inhibits histone H4-mediated cytotoxicity and strongly prevents organ tissue damage.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · S100 Proteins and Annexins · Neonatal and Maternal Infections

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering, University of California, Los Angeles, California 90095, United States

Institute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Münster, 48149 Münster, Germany

Institute for Cardiovascular Prevention (IPEK), LMU Munich, 80336 Munich, Germany

Department of Physics, University of Massachusetts, Amherst, Massachusetts 01003, United States

Ginkgo Bioworks, 27 Drydock Avenue, Boston, Massachusetts 02210, United States

Singapore Centre for Environmental Life Sciences Engineering (SCELSE), Nanyang Technological University, 60 Nanyang Drive, SBS-01N-27, Singapore 637551

Department of Physics, Syracuse University, Syracuse, New York 13244, United States

Department of Physiology and Pharmacology (FyFa), Karolinska Institute, 171 77 Stockholm, Sweden

Funding

Vetenskapsr??det · Biological and Environmental Research · National Institute of Allergy and Infectious Diseases · Deutsche Forschungsgemeinschaft · Else Kr??ner-Fresenius-Stiftung · National Institute of General Medical Sciences · Division of Materials Research · Fondation Leducq

References (68)

Show source-provided references
1. 10.1038/nri.2017.1010.1038/nri.2017.10 ↗
2. 10.1038/nri.2017.10510.1038/nri.2017.105 ↗
3. 10.1038/s41586-019-1167-610.1038/s41586-019-1167-6 ↗
4. 10.1038/nm.205310.1038/nm.2053 ↗
5. 10.1371/journal.pone.003236610.1371/journal.pone.0032366 ↗
6. 10.1073/pnas.160989311310.1073/pnas.1609893113 ↗
7. 10.1021/ja200079a10.1021/ja200079a ↗
8. 10.1016/S0005-2736(99)00201-110.1016/S0005-2736(99)00201-1 ↗
9. 10.1161/CIRCRESAHA.114.30235510.1161/CIRCRESAHA.114.302355 ↗
10. 10.1016/j.bbamem.2008.05.01410.1016/j.bbamem.2008.05.014 ↗
11. 10.1021/bi962785k10.1021/bi962785k ↗
12. 10.1016/0005-2736(95)00229-410.1016/0005-2736(95)00229-4 ↗
13. 10.1016/j.febslet.2009.11.04610.1016/j.febslet.2009.11.046 ↗
14. 10.1073/pnas.110879510810.1073/pnas.1108795108 ↗
15. 10.1016/S0022-2275(20)41536-610.1016/S0022-2275(20)41536-6 ↗
16. 10.1161/01.ATV.17.9.181310.1161/01.ATV.17.9.1813 ↗
17. 10.1006/bbrc.2000.421910.1006/bbrc.2000.4219 ↗
18. 10.1194/jlr.M03790310.1194/jlr.M037903 ↗
19. 10.1038/267465a010.1038/267465a0 ↗
20. 10.1016/S0022-2275(20)38532-110.1016/S0022-2275(20)38532-1 ↗
21. 10.1002/prot.34008020210.1002/prot.340080202 ↗
22. 10.1021/bi960760f10.1021/bi960760f ↗
23. 10.1016/j.plipres.2004.05.00210.1016/j.plipres.2004.05.002 ↗
24. 10.1074/jbc.R70001420010.1074/jbc.R700014200 ↗
25. Kontush, A.; Chapman, M. J. High-Density Lipoproteins: Structure, Metabolism, Function, and Therapeutics; John Wiley & Sons, Inc.: Hoboken, NJ, 2011; p 648.10.1002/9781118158678 ↗
26. 10.1021/bi980042o10.1021/bi980042o ↗
27. 10.1073/pnas.080362610510.1073/pnas.0803626105 ↗
28. 10.1073/pnas.72.12.494010.1073/pnas.72.12.4940 ↗
29. 10.1111/j.1432-1033.1976.tb10334.x10.1111/j.1432-1033.1976.tb10334.x ↗
30. 10.1161/01.ATV.0000165694.39518.9510.1161/01.ATV.0000165694.39518.95 ↗
31. 10.1016/j.atherosclerosis.2011.04.00110.1016/j.atherosclerosis.2011.04.001 ↗
32. 10.1194/jlr.M700552-JLR20010.1194/jlr.M700552-JLR200 ↗
33. 10.1161/CIRCRESAHA.110.21650710.1161/CIRCRESAHA.110.216507 ↗
34. 10.1172/JCI11751510.1172/JCI117515 ↗
35. 10.1016/S0022-2275(20)31163-910.1016/S0022-2275(20)31163-9 ↗
36. 10.2337/db10-084410.2337/db10-0844 ↗
37. 10.1007/s11883-009-0008-810.1007/s11883-009-0008-8 ↗
38. 10.1194/jlr.R700010-JLR20010.1194/jlr.R700010-JLR200 ↗
39. 10.1016/S0022-2275(20)31599-610.1016/S0022-2275(20)31599-6 ↗
40. 10.1056/NEJMra120862310.1056/NEJMra1208623 ↗
41. 10.1074/jbc.RA119.00968310.1074/jbc.RA119.009683 ↗
42. 10.1016/j.bbamem.2020.18330210.1016/j.bbamem.2020.183302 ↗
43. 10.1074/jbc.M110.12629210.1074/jbc.M110.126292 ↗
44. 10.1016/j.cossms.2013.09.00410.1016/j.cossms.2013.09.004 ↗
45. 10.1128/AAC.41.8.173810.1128/AAC.41.8.1738 ↗
46. 10.1016/0014-5793(93)80175-T10.1016/0014-5793(93)80175-T ↗
47. 10.1021/jp063006510.1021/jp0630065 ↗
48. 10.1111/j.1600-0854.2011.01286.x10.1111/j.1600-0854.2011.01286.x ↗
49. 10.1074/jbc.273.50.3311510.1074/jbc.273.50.33115 ↗
50. 10.1074/jbc.M80446120010.1074/jbc.M804461200 ↗
51. 10.1016/j.febslet.2013.01.02610.1016/j.febslet.2013.01.026 ↗
52. 10.1016/S0021-9258(18)32921-110.1016/S0021-9258(18)32921-1 ↗
53. 10.1161/CIRCULATIONAHA.113.00268310.1161/CIRCULATIONAHA.113.002683 ↗
54. 10.1007/s00134-006-0432-y10.1007/s00134-006-0432-y ↗
55. 10.1016/j.cyto.2008.04.00210.1016/j.cyto.2008.04.002 ↗
56. 10.1074/jbc.M113.46896710.1074/jbc.M113.468967 ↗
57. 10.1038/ni.278410.1038/ni.2784 ↗
58. 10.1093/cvr/cvu15010.1093/cvr/cvu150 ↗
59. 10.1194/jlr.R05136710.1194/jlr.R051367 ↗
60. 10.1586/14779072.6.9.120310.1586/14779072.6.9.1203 ↗
61. 10.1194/jlr.M700433-JLR20010.1194/jlr.M700433-JLR200 ↗
62. 10.1371/journal.pone.022693110.1371/journal.pone.0226931 ↗
63. 10.1016/j.clim.2008.01.01610.1016/j.clim.2008.01.016 ↗
64. 10.4049/jimmunol.100153410.4049/jimmunol.1001534 ↗
65. 10.1161/ATVBAHA.117.30952310.1161/ATVBAHA.117.309523 ↗
66. 10.1021/ja404714a10.1021/ja404714a ↗
67. 10.2174/13816121079329249210.2174/138161210793292492 ↗
68. 10.1194/jlr.P800003-JLR20010.1194/jlr.P800003-JLR200 ↗